NCT04201262 2025-10-14
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
Clinical Trials
7 trialsNCT04155424 2024-09-25
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 2/3 Terminated
NCT05491525 2024-07-03
KANGUROO
Urovant Sciences GmbH
Phase 2/3 Recruiting
NCT03887273 2023-08-21
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Q Therapeutics, Inc.
Phase 1/2 Unknown
NCT02003144 2022-08-23
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT01892345 2019-06-26
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Alexion Pharmaceuticals, Inc.
Phase 3 Terminated
NCT03138421 2019-01-25
Central Pain Study for ABX-1431
Abide Therapeutics
Phase 1 Completed